Last reviewed · How we verify
NCT06095518: DIC-ECMO
DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
trial testing DIC markers and Thrombin Generation Parameters in Extracorporeal Circulation; Complications in 50 participants. Currently enrolling.
7 April 2025
Quick facts
| Lead sponsor | Queen Mary Hospital, Hong Kong |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 30 May 2023 |
| Primary completion | 7 April 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- DIC markers and Thrombin Generation Parameters
Conditions studied
- Extracorporeal Circulation; Complications — all drugs for Extracorporeal Circulation; Complications →
- Extracorporeal Membrane Oxygenation Complication — all drugs for Extracorporeal Membrane Oxygenation Complication →
Sponsor
Queen Mary Hospital, Hong Kong
Who can join
Under 80, any sex, with Extracorporeal Circulation; Complications or Extracorporeal Membrane Oxygenation Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To study the correlation between novel DIC markers and thrombin generation parameters with thrombotic and hemorrhagic complications of patients on ECMO support.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06095518
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Extracorporeal Circulation; Complications
Currently open trials in the same condition.
- NCT06754709 — Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children · recruiting
- NCT06179771 — Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support. · NA · recruiting
- NCT05669183 — Hemodynamic Comparison of Peripheral and Central VA ECMO. · recruiting
- NCT05487612 — MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS) · NA · recruiting
Other Queen Mary Hospital, Hong Kong trials
Trials by the same sponsor.
- NCT07461064 — HIFU vs Observation for LSIL of Cervix: A Randomized Controlled Trial · NA · not yet recruiting
- NCT06178471 — Safety, Feasibility and Clinical Utility of Critical Care Transesophageal Echocardiography in Hong Kong · not yet recruiting
- NCT06037356 — PUL vs TURP in BPH Patients With Urinary Retention · NA · recruiting
- NCT06643416 — Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia · Phase 3 · recruiting
- NCT06551337 — Vitamin D Replacement in Bronchiectasis · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06095518 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen Mary Hospital, Hong Kong
- Last refreshed: 24 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06095518.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing